Based on our findings, DPP3, GLRA3, CRCP, CHRNA5, CHRNE, and CHRNB1 genes that are involved in neurotransmitter pathways were found to be downregulated in the NK cells of AML patients as well. The gene discussed is CRCP; the disease is acute myeloid leukemia.